Buy or sell Blaze Bioscience stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Blaze Bioscience Stock

Blaze Bioscience develops and commercializes products that assist surgeons to treat cancer patients.

About Blaze Bioscience Stock

Blaze Bioscience is a Seattle-based, privately-held biotechnology company dedicated to developing products that assist surgeons in their quest to improve the lives of cancer patients. The company was founded in 2010 to develop and commercialize the Tumor Paint technology. Tumor Paint provides real-time, highresolution intraoperative visualization of cancer cells, enabling better detection and more complete and precise surgical resection of cancer. The first Tumor Paint product candidate, which is a combination of a targeting peptide and a fluorescent beacon, is under development for multiple solid tumors.

Funding History

June 2012$6.4M
June 2015$9.7M
April 2016$0
October 2017$16.1M
May 2018$3.0M



James Olson

President & CEO

Heather Franklin

Senior Director of Process Development & Manufacturing

Claudia Jochheim

Vice President, Research & Project Management

Julia Novak

Vice President, Finance & Operations

Mila Lobanova

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Blaze Bioscience or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 260K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: